According to an article in the Washington Post: The Food…
““According to an article in the Washington Post: The Food and Drug Administration has repeatedly urged antidepressant manufacturers not to disclose to physicians and the public that some clinical trials of the medications in children found that drugs were no better than sugar pills, according to documents and testimony released at a congressional hearing yesterday. Regulators supressed the negative information on the grounds that it might scare families and physicians away from the drugs, according to testimony by drug company executives. For at least three medications, they said, the FDA blocked the companies' plans to reveal the negative studies in drug labels.””
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
The FDA suppressed negative pediatric trial results for antidepressants to avoid discouraging use, prioritizing market confidence over full transparency.
In simple terms: FDA hid bad data to keep drug sales up.
Key Takeaway
Demand full disclosure of trial outcomes.
Themes
transparency
ethics
pharmaceuticals
regulation
public health
Mood
concerned
critical
inquisitive
Type
policy
ethical
informative
When to use this quote
- medical conferences
- policy making
- patient counseling
- media reporting
Key Concepts
conflict of interest
risk communication
patient safety
Questions to Reflect On
- How would full disclosure affect prescribing habits?
- What safeguards can prevent similar suppression?
A Different Perspective
Suppressing data can erode trust and harm patients.